SuperworthGE HealthCare Technologies price to sales ratio GEHC
Market value divided by revenue over the last twelve months, since 2024.
- Today, Oct 23, 2026
- 1.5×
- 3-year median
- 1.8×
- Against its 3-year history
- 17th
- percentile: 0 is its lowest day, 100 its highest
- 3-year range
- 1.3× to 2.2×
- Peer median
- 3.2×
GE HealthCare Technologies' price to sales ratio is 1.5× as of Oct 23, 2026.
That is below its 3-year median of 1.8×, lower than on 83% of days in the last 3 years.
Over that time it ranged from 1.3× in Jul 2026 to 2.2× in Mar 2024.
The median for 9 medical device stocks of a similar size is 3.2×.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 1.5× | 1.3× | 2.0× |
| 2025 | 1.9× | 1.4× | 2.1× |
| 2024 | 1.9× | 1.8× | 2.2× |
Against its peers
Companies in Medical - Devices nearest GE HealthCare Technologies' size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| GEHCGE HealthCare Technologies | 1.5× |
| DXCMDexCom | 5.9× |
| EWEdwards Lifesciences | 7.9× |
| ZBHZimmer Biomet | 2.2× |
| BSXBoston Scientific | 3.2× |
| SYKStryker | 4.6× |
| MDTMedtronic | 3.3× |
| ABTAbbott Laboratories | n/m |
| LIVNLivaNova | 3.0× |
| ITGRInteger | 2.3× |
| Peer median | 3.2× |
Where GE HealthCare Technologies ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on GE HealthCare Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.